Has Patricia Wagner received payments from drug or device companies?

Yes. Drug and device makers reported $2,893 in general payments to Patricia Wagner across 144 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Patricia Wagner did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Patricia Wagner come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Patricia Wagner

Adult Health · Buffalo, NYNPI 1306195078

Payments from drug & device makers

$2,893in general payments, 2019–2025

Across 144 payments — averaging $20.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$521
Novo Nordisk$512
Lilly USA, LLC$366
GSK$271
Pfizer$215
Boehringer Ingelheim$195
plus $814 from 15 others

What the payments were for

Food & beverage$2,882100%
Education$110%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca	21	$521
Novo Nordisk	28	$512
Lilly USA, LLC	21	$366
GSK	11	$271
Pfizer	11	$215
Boehringer Ingelheim	11	$195
Amgen	5	$101
Exact Sciences	4	$87
E.r. Squibb & Sons, L.L.C.	5	$77
Abbott	3	$73
Dexcom, Inc.	4	$72
AbbVie	4	$70
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	3	$66
Phathom Pharmaceuticals, Inc.	3	$55
VBI Vaccine (delaware) Inc.	2	$55
Merck	2	$46
Sanofi-aventis U.S. LLC	2	$30
Edwards Lifesciences	1	$28
Indivior Inc.	1	$20
Teva Pharmaceuticals USA, Inc.	1	$18
Paratek Pharmaceuticals, Inc.	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,893 in reported general payments places this provider in the 85th percentile of 3,828 adult health providers in New York.

See all adult health providers in New York →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
JardianceEmpagliflozin	130	$146,222
EliquisApixaban	148	$134,963
OzempicSemaglutide	100	$126,665
TrulicityDulaglutide	48	$64,252
XareltoRivaroxaban	47	$40,291
FarxigaDapagliflozin Propanediol	28	$28,718
Trelegy ElliptaFluticasone/Umeclidin/Vilanter	25	$25,183
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog	35	$20,738
Fluticasone-SalmeterolFluticasone Propion/Salmeterol	77	$17,183
InvokanaCanagliflozin	12	$16,691
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr	32	$15,661
Atorvastatin Calcium	826	$15,407
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog	12	$11,469
Spiriva HandihalerTiotropium Bromide	17	$10,302
Lantus SolostarInsulin Glargine,hum.Rec.Anlog	57	$9,957

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Boehringer IngelheimJardiance, Stiolto Respimat	$195	$152,243143 claims
PfizerEliquis	$215	$134,963148 claims
Novo NordiskOzempic	$512	$126,665100 claims
Lilly USA, LLCTrulicity	$366	$64,25248 claims
GSKTrelegy Ellipta, Anoro Ellipta, Shingrix	$271	$43,48769 claims
AstraZenecaFarxiga, Symbicort	$521	$32,04142 claims
AbbVieSynthroid	$70	$3,86761 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,828 adult health providers in New York.

Other adult health in Buffalo

Mary CiechoskiBuffalo$200K
Rosemary HansenBuffalo$40K
Susan DemarcoBuffalo$20K
Marguerite CallahanNew York$1.4M
Donna CatameroNew York$279K
Kristen DurkinPort Jefferson Station$255K
Katelyn McCormackAmherst$201K
Patricia LorussoLancaster$161K
Jennifer FioriniGlens Falls$151K
Tia AlbroRochester$142K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →